Post by account_disabled on Jan 9, 2024 6:06:45 GMT
AstraZeneca's COVID- 19 vaccine ( ChAdOx1-S [Recombinant]) was invented by Oxford University. The vaccine was developed by Cycle of genetic material used To decipher the formation of protein spikes The cell surface of the SARS-CoV-2 coronavirus is inserted into an adenovirus structure, which cause general influenza in the A chimpanzee that was weakened It weakens and cannot divide itself.
After inoculation with intracellular cells The human Special Data body will respond by creating of proteins that have the same characteristics The protein spikes on the cell surface of the coronavirus SARS -CoV-2 stimulate the The body builds up immunity to to fight the SARS-CoV-2 virus in cases of exposure to the virus will cause the body later AstraZeneca's COVID- 19 vaccine It is a viral vector vaccine, which is a vaccine that has been developed. Developed by taking a weakened virus and depositing the genetic material of COVID-19.
Into it, which makes it impossible to divide and cannot cause can cause disease in humans During the past 40 years, scientists have often used This vaccine technology fights other viral infections such as influenza , Ebola , and HIV 14 , etc. AstraZeneca's COVID- 19 vaccine has been approved. It is registered for emergency use in more than 90 countries and is registered for emergency use in more than 90 countries.
After inoculation with intracellular cells The human Special Data body will respond by creating of proteins that have the same characteristics The protein spikes on the cell surface of the coronavirus SARS -CoV-2 stimulate the The body builds up immunity to to fight the SARS-CoV-2 virus in cases of exposure to the virus will cause the body later AstraZeneca's COVID- 19 vaccine It is a viral vector vaccine, which is a vaccine that has been developed. Developed by taking a weakened virus and depositing the genetic material of COVID-19.
Into it, which makes it impossible to divide and cannot cause can cause disease in humans During the past 40 years, scientists have often used This vaccine technology fights other viral infections such as influenza , Ebola , and HIV 14 , etc. AstraZeneca's COVID- 19 vaccine has been approved. It is registered for emergency use in more than 90 countries and is registered for emergency use in more than 90 countries.